These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Venlafaxine XR in the treatment of anxiety. Hackett D Acta Psychiatr Scand Suppl; 2000; (406):30-5. PubMed ID: 11131468 [TBL] [Abstract][Full Text] [Related]
4. Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder. Sheehan DV J Clin Psychiatry; 1999; 60 Suppl 22():23-8. PubMed ID: 10634352 [TBL] [Abstract][Full Text] [Related]
5. Comorbid depression and anxiety spectrum disorders. Gorman JM Depress Anxiety; 1996-1997; 4(4):160-8. PubMed ID: 9166648 [TBL] [Abstract][Full Text] [Related]
6. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings. Zajecka JM J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357 [TBL] [Abstract][Full Text] [Related]
7. Treatment of major depression: is improvement enough? Ferrier IN J Clin Psychiatry; 1999; 60 Suppl 6():10-4. PubMed ID: 10235119 [TBL] [Abstract][Full Text] [Related]
8. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder. Silverstone PH; Salinas E J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362 [TBL] [Abstract][Full Text] [Related]
11. An open-label trial of nefazodone in high comorbidity panic disorder. DeMartinis NA; Schweizer E; Rickels K J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561 [TBL] [Abstract][Full Text] [Related]
12. Treatment of anxiety disorders with venlafaxine XR. Thase ME Expert Rev Neurother; 2006 Mar; 6(3):269-82. PubMed ID: 16533131 [TBL] [Abstract][Full Text] [Related]
13. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder. Bose A; Korotzer A; Gommoll C; Li D Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245 [TBL] [Abstract][Full Text] [Related]
14. Clinical guidelines for establishing remission in patients with depression and anxiety. Ballenger JC J Clin Psychiatry; 1999; 60 Suppl 22():29-34. PubMed ID: 10634353 [TBL] [Abstract][Full Text] [Related]
15. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group. Silverstone PH; Ravindran A J Clin Psychiatry; 1999 Jan; 60(1):22-8. PubMed ID: 10074873 [TBL] [Abstract][Full Text] [Related]
17. Extended-release formulation of venlafaxine in the treatment of post-traumatic stress disorder. Pae CU; Lim HK; Ajwani N; Lee C; Patkar AA Expert Rev Neurother; 2007 Jun; 7(6):603-15. PubMed ID: 17563244 [TBL] [Abstract][Full Text] [Related]
18. Extended-release venlafaxine in relapse prevention for patients with major depressive disorder. Simon JS; Aguiar LM; Kunz NR; Lei D J Psychiatr Res; 2004; 38(3):249-57. PubMed ID: 15003430 [TBL] [Abstract][Full Text] [Related]
19. Once-daily venlafaxine XR compared with fluoxetine in outpatients with depression and anxiety. Judge R; Wagner BE J Clin Psychiatry; 1999 Nov; 60(11):795-6. PubMed ID: 10584775 [No Abstract] [Full Text] [Related]
20. Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients. Feighner JP; Entsuah AR; McPherson MK J Affect Disord; 1998 Jan; 47(1-3):55-62. PubMed ID: 9476744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]